You just read:

Lumosa to Initiate Phase 2 Human Clinical Trial in the US and Taiwan for Its LT3001, A Novel Drug for the Treatment of Acute Ischemic Stroke

News provided by

Lumosa Therapeutics Co., Ltd.

Jun 13, 2019, 08:00 ET